XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,002,592 | -23.6% | 5,915,372 | +7.5% | 3.66% | -29.7% |
| Q2 2023 | $14,410,597 | +2.3% | 5,500,228 | -36.3% | 5.20% | +10.1% |
| Q1 2023 | $14,083,534 | -5.4% | 8,640,205 | -22.8% | 4.72% | -24.6% |
| Q4 2022 | $14,889,601 | -26.2% | 11,195,189 | -13.4% | 6.26% | -30.9% |
| Q3 2022 | $20,168,000 | +12.4% | 12,928,168 | +11.0% | 9.07% | +8.7% |
| Q2 2022 | $17,937,000 | -11.6% | 11,647,417 | +47.0% | 8.34% | -0.8% |
| Q1 2022 | $20,286,000 | +22.4% | 7,924,056 | +40.1% | 8.41% | +10.6% |
| Q4 2021 | $16,573,000 | – | 5,656,373 | – | 7.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
| Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
| MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
| Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
| EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
| DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
| Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
| Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
| IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |